Transfemoral TAVR Evolut-Pro (26mm) and Sentinel Cerebral Protection – July 2017

93 year old female presented with progressive dyspnea (NYHA Class III). Past medical history is significant for CAD (s/p PCI to LAD in 2016), hypertension, hypercholesterolaemia and aortic stenosis under surveillance. Recent echocardiogram revealed progression to severe aortic stenosis (PG/MG/AVA 92mmHg/51mmHg/0.74cm2) and LVEF of 68%. CT angiogram revealed > 6mm diameter of bilateral common iliac arteries and aortic annulus of 22x18mm (average 20.5m) with annular perimeter of 67mm. STS mortality risk for surgical AVR was 10.1% and the logistic Euroscore mortality risk was 17.1%. Patient underwent surgical evaluation and was found to be at high risk for SAVR. Now presented for percutaneous transfemoral TAVR with Evolut-Pro 26mm valve and Sentinel cerebral protection device.

45:24

Comments

One Comment
gasperetti
08 Jul, 2017

thank you! great case again
much obliged

Reply

Leave a Reply

Your email address will not be published.*


By submitting this form, you are consenting to receive marketing emails from: Mount Sinai Hospital, One Gustave L. Levy Place, Box, New York, NY, 10029, https://ccclivecases.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact